Ciclosporin/tacrolimus: De novo lupus-like glomerulonephritis: 7 case reports.

Patient 4 from table 2 of the article: A 17-year-old boy, who had de novo autoimmune hepatitis, hepatic artery thrombosis and biliary atresia, underwent three liver transplantations. B Author Information b An event is serious (based on the ICH definition) when the patient outcome is: * death * life-threatening * hospitalisation * disability * congenital anomaly * other medically important event In a retrospective study involving 786 patients performed at UCLA Mattel Children's Hospital, USA between January 1993 and May 2018, seven patients (3 girls and 4 boys) aged 4-17 years were described, who developed de novo lupus-like glomerulonephritis (DNLLGN) following treatment with tacrolimus or ciclosporin as immunosuppressive therapy [ I routes, dosages and duration of treatments to reactions onsets not stated i ]. Patient 7 from table 2 of the article: A 6-year-old boy, who had psoriasis, gastroschisis, short gut syndrome, prematurity, intestinal failure and asocial liver disease, underwent liver and small bowel transplantations. [Extracted from the article]